| Similar Articles |
|---|
 |
Chemistry World
July 29, 2013
Hepeng Jia |
China corruption investigation broadens Investigations of corrupt practices at GlaxoSmithKline in China are continuing. But analysts claim that the scandal is an attempt to remodel the Chinese drugs market, rather than a deliberate attack on international companies.   |
Chemistry World
September 25, 2014
Hepeng Jia |
GSK fined 300 million for China corruption After investigation by Chinese police, the British pharmaceutical giant GlaxoSmithKline was fined a record Yuan3 billion ( 300 million pounds) for bribing Chinese doctors and hospital officials. |
Chemistry World
August 29, 2013
Emma Stoye |
Couple charged in GSK corruption investigation A UK consultant and his American wife have been charged in relation to the corruption investigation at GlaxoSmithKline in China. |
Chemistry World
July 12, 2013
Phillip Broadwith |
GSK under investigation over corruption in China Chinese police are investigating GlaxoSmithKline over claims of bribery and tax-related crimes. |
Chemistry World
May 14, 2014
Phillip Broadwith |
Chinese police hand GSK bribery case to prosecutors The Chinese state news agency Xinhua has released details of the police investigation, claiming that 46 suspects are involved including Mark Reilly, former manager of GSK China. |
Chemistry World
April 9, 2014
Emma Stoye |
GSK investigates bribery claims in the Middle East GlaxoSmithKline has been accused of bribing doctors and healthcare officials in Iraq in emails leaked to the Wall Street Journal by a whistleblower. |
BusinessWeek
July 8, 2010
Dexter Roberts |
The Higher Costs of Bribery in China The U.S. is policing the activities of big multinationals in China more aggressively, with China's own prosecutors sometimes following suit. |
CFO
April 1, 2007
Wu Chen |
View from China: Shanghai Confidential Risk-management advisers to foreign companies say investigations of multinationals suggest it's time to take a close look at internal controls in the People's Republic. |
Chemistry World
May 30, 2007
Hepeng Jia |
Disgraced Drug Chief Sentenced to Death As China battles to root out corruption from its pharmaceutical sector, the former head of the State Food and Drug Agency, Zheng Xiaoyu, has been sentenced to death after being found guilty of taking bribes. |
Chemistry World
January 30, 2007
Bea Perks |
BBC and GSK Battle Over Seroxat The UK pharmaceutical giant, which has spent the past few years fighting off accusations of risks associated with its market-leading anti-depressant, has rejected fresh claims that it improperly withheld medical trial information in the 1990s. |
Entrepreneur
September 2004
Jane Easter Bahls |
Illicit Affairs? If you do business overseas, be certain your "administrative fees" aren't really illegal bribes. And because complying with the many overlapping laws is tricky, hire a lawyer with experience in international business. |
The Motley Fool
September 15, 2011
Frank Vinluan |
GSK's New Drug Marketing Model: Pharma Reps As Educators, Not Sellers The conversation between sales reps and doctors today is vastly different compared to one year ago. |
Chemistry World
October 7, 2015
Phillip Broadwith |
Bristol-Myers-Squibb fined for alleged Chinese bribes The US Securities and Exchange Commission has fined New York based pharmaceutical company Bristol-Myers Squibb over $14 million over alleged bribes made to Chinese state owned hospitals. |
Pharmaceutical Executive
August 1, 2013
William Looney |
One Company -- One Moment The trade media is ablaze with lurid accounts of bribery, tax fraud, and other illicit promotional activities in China -- ironically, the country touted as guarantor of our industry's future. |
BusinessWeek
March 10, 2011
Dexter Roberts |
China's Ruling Party Vows to Root Out Corruption Premier Wen Jiabao calls for a crackdown on the abuses of the Communist cadres. |
BusinessWeek
December 6, 2004
Matlack, Smith & Edmondson |
Cracking Down On Corporate Bribery With tougher laws in place, prosecutors around the world are bringing high-profile cases to court. |
Chemistry World
June 10, 2014
Anthony King |
Drug giants settle mismarketing lawsuits Pfizer and GlaxoSmithKline recently agreed to separate settlements over allegations of mismarketing drugs in the US. |
CFO
January 1, 2005
David M. Katz |
The Bribery Gap While foreign rivals may make payoffs routinely, U.S. firms face new pressure to root out abuses. |
BusinessWeek
November 26, 2007
Jack Ewing |
Siemens Braces for a Slap from Uncle Sam After paying huge fines in Germany for bribery, Siemens faces even stiffer penalties in the U.S. |
Chemistry World
May 18, 2007
Hepeng Jia |
China's Battle with Fake Drugs While China's pharmaceutical industry is experiencing rapid growth, a boom in counterfeit drugs is costing human lives and eroding the public's confidence in medical products. |
National Defense
September 2015
Kopp & Bhatia |
U.S. Cracking Down on Defense Industry Corruption Overseas The race for international sales during the past few years has been followed by a wave of government investigations into defense companies for both major and relatively minor violations of the Foreign Corrupt Practices Act. |
National Defense
August 2006
Shaheen & Bombach |
Anti-Bribery Enforcement On the Increase Overseas U.S. government contractors involved in overseas sales recognize the need to comply with the anti-bribery provisions of the U.S. Foreign Corrupt Practices Act. |
The Motley Fool
November 3, 2011
Frank Vinluan |
GSK Settles With Uncle Sam for $3B GSK said the settlement will reduce financial uncertainty for the company and is in the best interest of shareholders. |
The Motley Fool
October 26, 2006
Brian Lawler |
Glaxo's Prescription for Sagging Sales Trading at roughly 32 times its trailing-12-month earnings, and with a solid 2.9% dividend yield, GSK is a fine investment for shareholders patient enough to wait until 2008 for a return to solid revenue growth. |
Chemistry World
July 25, 2014
Hepeng Jia |
Scientists and university officials caught up in China's anti-corruption drive Dozens of university officials and leading scientists in China have been arrested or imprisoned as part of the new government's drive to stamp out corruption. |
| Knowledge@Wharton |
How Bribery and Other Types of Corruption Threaten the Global Marketplace There's no doubt that corruption, endemic in emerging economies around the world, throws economic development into chaos. Today, the creation of and comment on anti-corruption regimes is a growth industry. |
The Motley Fool
January 19, 2011
Cliff D'Arcy |
Glaxo Stung by Legal Bill GSK shareholders are hit by costly legal settlements. |
Chemistry World
April 23, 2014
Phillip Broadwith |
GSK corruption investigation widens Pharma giant GlaxoSmithKline has responded to allegations made by the BBC's Panorama program concerning improper conduct by GSK's sales staff in Poland. |
HBS Working Knowledge
November 24, 2014
Michael Blanding |
Corrupting Silence: Companies Must Speak Up Against Bribes Does corruption really pay? Paul Healy finds that corruption may not be as lucrative - -or as unavoidable -- as it may seem. |
The Motley Fool
June 14, 2007
Brian Lawler |
Dueling Fools: GlaxoSmithKline Bull Shares of the pharmaceutical may be temporarily down, but it's not out. |
The Motley Fool
July 11, 2007
Brian Lawler |
Not All Pharmaceutical Markets Are the Same The case of China's former FDA leader highlights the issues facing the country's pharmaceutical industry. Investors, take note. |
Chemistry World
July 13, 2007
Hepeng Jia |
Chinese Legislation to Increase Drug Safety A long-awaited amendment to China's drug registration system is expected to discipline the country's medical sector and boost the pharmaceutical industry. |
Chemistry World
October 11, 2007
Hepeng Jia |
China's Drug Industry Set to Take Off Producing cheap drugs for the developing world could allow Chinese pharmaceutical firms to capture a bigger share of the international market, industry experts suggest. |
BusinessWeek
December 13, 2004
Bruce Einhorn |
Go East, Big Pharma Drugmakers are expanding in China, but patents are still a worry. |
The Motley Fool
September 28, 2007
Brian Lawler |
GSK Helps Secure Future of a Lead Drug GlaxoSmithKline settles a patent infringement case on a lead drug, Avandia, and with that challenger gone, the company is a step closer to securing one of its top franchises. |
Chemistry World
March 11, 2015
Rebecca Trager |
Mergers and moves trigger pharma layoffs Downsizing in the pharmaceutical industry is discussed. |
The Motley Fool
January 8, 2004
Rich Smith |
Oops, I(BM) Did it Again Once again IBM finds itself embattled in bribing controversy abroad. |
The Motley Fool
September 25, 2008
Brian Lawler |
Eli Lilly's Dose of Disclosure The pharmaceutical pledges public reports of its dealings with doctors. |
Chemistry World
September 30, 2014 |
Transparency measures forced on pharma Previous misdemeanors are compelling the pharmaceutical industry to be more open with financial information and clinical data. |
Pharmaceutical Executive
August 1, 2005
Lena Chow |
Docs of Shanghai They're short on status, pay, and respect, but China's young doctors hold keys to the world's fastest growing pharmaceutical market. |
The Motley Fool
April 15, 2011
Frank Vinluan |
GSK to Shed Weight Loss Drug alli and 18 Others GSK wants to focus on fast-growing "priority brands." |
Chemistry World
May 16, 2013
Anthony King |
GSK partners Save the Children for Africa project Pharma giant GSK is to partner the international charity Save the Children in a five year deal, which it says aims to help save the lives of one million children. The controversial compact offers a blueprint for how businesses and non-government organizations can work together, says GSK. |
Chemistry World
April 25, 2014
Andy Extance |
$25bn-plus trade sharpens pharma giants' focus Three leading pharmaceutical firms are set to exchange business segments valued at over $25 billion, in deals affecting at least 14,000 employees. |
Chemistry World
December 5, 2014
Andy Extance |
GSK cuts US jobs in push for savings 350 of the chemists, engineers and other roles will be lost by April 2015, another 450 by July, and the remainder eliminated by the end of the year. |
The Motley Fool
July 26, 2011
Cliff D'Arcy |
GSK Showers Shareholders With Cash GlaxoSmithKline, the U.K.'s largest pharmaceutical company, has released its second-quarter results. Thanks to rising earnings and dividends, its shares remain attractively priced, particularly to income-seeking investors. |
The Motley Fool
April 5, 2011
Frank Vinluan |
GSK in Emerging Markets: Why Sales Staff There Are Key to Global Strategy GlaxoSmithKline's rivalry with top drug companies such as Pfizer goes beyond the products they sell. In some emerging markets, it now also extends to the staff they're fighting to keep. |
Chemistry World
November 16, 2009
Hepeng Jia |
Chinese NASDAQ brings little to chemicals industry Similar to the US NASDAQ, most of the listed firms in the Chinese GEM are technology-oriented companies. Classified by industry, electronics and pharmaceutical manufacturers are the biggest groups |
The Motley Fool
April 19, 2010
Rich Smith |
Hewlett-Packard: International Criminal Mastermind? Or is H-P just a patsy? |
IDB America
May 2005
Alexandra Russell-Bitting |
Proven Tactics for the War on Corruption International experts trade tips on fighting fraud and abuse in the public sector. |
CFO
June 1, 2007
Janet Kersnar |
View from Europe: Global Bribery A series of bribery scandals in Europe becomes a global issue. |
